SCHEMBL436740

SCHEMBL436740

O=C(OC(=O)C(O)C(O)C(=O)O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TSHR P16473 5/20 0.50
TP53 P04637 1/20 0.50
LMNA P02545 2/20 0.48
F2 P00734 1/20 0.48
TDP1 Q9NUW8 3/20 0.46
KMT2A Q03164 3/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
PRKCA P17252 1/20 0.42
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 2/20 0.41
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
SLC1A5 Q15758 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8838858 1.00 ALDH1A1 (0.52) ALDH1A1TSHRTP53LMNAF2
Water SCHEMBL27446036 0.98 ALDH1A1 (0.50) ALDH1A1TSHRTP53LMNAF2
Water SCHEMBL27446035 0.98 ALDH1A1 (0.50) ALDH1A1TSHRTP53LMNAF2
SCHEMBL6658799 0.98 ALDH1A1 (0.50) ALDH1A1TSHRTP53LMNAF2
SCHEMBL6659868 0.98 ALDH1A1 (0.50) ALDH1A1TSHRTP53LMNAF2
SCHEMBL670258 0.94 ALDH1A1 (0.57) ALDH1A1TSHRTP53LMNAF2
SCHEMBL1162598 0.94 ALDH1A1 (0.57) ALDH1A1TSHRTP53LMNAF2
SCHEMBL582331 0.94 ALDH1A1 (0.57) ALDH1A1TSHRTP53LMNAF2
SCHEMBL420405 0.94 ALDH1A1 (0.57) ALDH1A1TSHRTP53LMNAF2
Water SCHEMBL1660792 0.92 ALDH1A1 (0.55) ALDH1A1TSHRTP53LMNAF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101959870-B Preparation of morpholine derivatives SANDOZ AG 2013-10-16 CN claimed
CN-101959870-A Preparation of morpholine derivatives SANDOZ AG 2011-01-26 CN claimed
CN-101514163-A Optically pure Sibutramine and process for preparing salt derivative thereof GUANGZHOU HUIHONG BIOPHARMACEU (CN) 2009-08-26 CN claimed
CN-101137654-A Novel salt of quinuclidine derivative ASTELLAS PHARMA INC (JP) 2008-03-05 CN claimed
CN-1315777-C Process for recovering optically active diacyltartaric acids TORAY FINECHEMICALS CO LTD (JP) 2007-05-16 CN claimed
CN-1738791-A Process for recovering optically active diacyltartaric acids TORAY FINECHEMICALS CO LTD (JP) 2006-02-22 CN claimed
CN-1729192-A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors PFIZER PROD INC (US) 2006-02-01 CN claimed
CN-1211366-C Methyl sulfonate trihydrate of 1-(4-hydroxy phenyl)-2-(4-hydroxy-4-phenyl piperid-1-yl)-1-propanol and its intermidiate preparing process PFIZER PROD INC (US) 2005-07-20 CN claimed
CN-1322716-A Methyl sulfonate trihydrate of 1-(4-hydroxy phenyl)-2-(4-hydroxy-4-phenyl piperid-1-yl)-1-propanol and its intermidiate preparing process PFIZER PROD INC (US) 2001-11-21 CN claimed
US-6194593-B1 USEFUL AS LIGAND FOR AN ASYMMETRIC CATALYST FOR USE IN ASYMMETRICAL HYDROGENATION NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2001-02-27 US claimed
CN-87102402-A New optically-active compound 1987-10-07 CN claimed
CN-114524812-A Crystal form preparation and synthesis method of 1, 4-dihydro-1, 6-naphthyridine compound 湖南凯铂生物药业有限公司 2022-05-24 CN disclosed
CN-110724146-B Preparation method of tofacitinib citrate 四川大学 2022-03-11 CN disclosed
CN-113214270-A Compounds and derivatives thereof as MDM2-P53 inhibitors 勃林格殷格翰国际有限公司 2021-08-06 CN disclosed
CN-108137590-B Spiro (3H-indol-3, 2' -pyrrolidin) -2(1H) -one compounds and their derivatives as MDM2-P53 inhibitors 勃林格殷格翰国际有限公司 2021-04-09 CN disclosed
CN-87102402-A New optically-active compound 1987-10-07 CN disclosed
EP-0140830-A2 Pharmaceutical preparations containing flavene or thioflavene derivatives, the use thereof, novel flavenes and thioflavenes, and processes for their manufacture Zyma SA (CH) 1985-05-08 EP disclosed
EP-0139615-A2 Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter Zyma SA (CH) 1985-05-02 EP disclosed
EP-0074903-A2 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene, their preparation and their therapeutic use SYNTHELABO (FR) 1983-03-23 EP disclosed
US-4110360-A FROM AN ALDEHYDE, ACID HALIDE AND CYANIDE SHELL OIL COMPANY (US) 1978-08-29 US disclosed